A. Ivanov

发表

Highly diverse, massive organic data as explored by a composite QSPR strategy: An advanced study of boiling point

V. A. Palyulin, A. A. Ivanova, A. Ivanov, 2005, SAR and QSAR in environmental research.

Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

Margaret A. Johns, A. Marcus, F. Khuri, 2017, Nature Communications.

Targeting protein-protein interactions as an anticancer strategy.

F. Khuri, H. Fu, A. Ivanov, 2013, Trends in pharmacological sciences.

Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.

K. Jacobson, Zhang-Guo Gao, T. K. Harden, 2006, Biochemical pharmacology.

Molecular Modeling of the Human A2a Adenosine Receptor

V. A. Palyulin, A. Ivanov, N. Zefirov, 2003, Doklady Biochemistry and Biophysics.

1E7‐03, a low MW compound targeting host protein phosphatase‐1, inhibits HIV‐1 transcription

K. Kehn-Hall, S. Nekhai, A. Üren, 2014, British journal of pharmacology.

Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

K. Jacobson, A. Ivanov, P. Baraldi, 2009, Handbook of experimental pharmacology.

Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling

Stefano Costanzi, Kenneth A. Jacobson, Andrei A. Ivanov, 2006, J. Comput. Aided Mol. Des..

Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.

K. Jacobson, T. K. Harden, P. Kováč, 2009, Bioorganic & medicinal chemistry.

Development of selective agonists and antagonists of P2Y receptors

K. Jacobson, T. K. Harden, S. de Castro, 2008, Purinergic Signalling.

Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides.

K. Jacobson, Zhang-Guo Gao, K. Palaniappan, 2007, Biochemistry.

Agonists and antagonists for P2 receptors.

K. Jacobson, S. Costanzi, A. Ivanov, 2006, Novartis Foundation symposium.

LKB 1 , and YAP 1 revealed as MYC interactors with NanoLuc-based protein-fragment complementation assay

Margaret A. Johns, Russell, L. Cooper, 2017 .

Molecular Modeling the Human A1 Adenosine Receptor and Study of the Mechanisms of Its Selective Ligand Binding

V. A. Palyulin, A. Ivanov, N. Zefirov, 2002, Doklady Biochemistry and Biophysics.

Molecular modelling of the human A2b adenosine receptor and an analysis of the binding modes of its selective ligands

V. A. Palyulin, A. Ivanov, N. Zefirov, 2002 .

Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

K. Jacobson, T. K. Harden, A. Ivanov, 2009, Bioconjugate chemistry.

Probing distal regions of the A2B adenosine receptor by quantitative structure-activity relationship modeling of known and novel agonists.

K. Jacobson, Zhang-Guo Gao, A. Ivanov, 2008, Journal of medicinal chemistry.

Maternal - Fetal Interaction: An Insight through the Stable Isotope Fractionation Prism

A. Ivanov, Y. Doronin, P. D. Golichenkova, 2012 .

Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.

K. Jacobson, T. K. Harden, S. Costanzi, 2007, Journal of medicinal chemistry.

Renewal versus retention: isotopic composition of intestinal epithelium and eye lens.

A. Ivanov, Y. Doronin, D. Y. Bednik, 2013 .

Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor.

K. Jacobson, T. K. Harden, A. Ivanov, 2007, Journal of medicinal chemistry.

Design, synthesis, and bioactivity of putative tubulin ligands with adamantane core.

D. Weiss, H. Lemcke, N. S. Zefirov, 2008, Bioorganic & medicinal chemistry letters.

Design, synthesis and bioactivity of simplified taxol analogues on the basis of bicyclo[3.3.1]nonane derivatives

D. Weiss, H. Lemcke, A. Ivanov, 2008 .

Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.

K. Jacobson, Zhang-Guo Gao, A. Ivanov, 2007, Journal of medicinal chemistry.

An estimation of the stability of cyclic ester addition compounds formed by group IV elements, by the MO LCAO method in the Hückel approximation

A. Ivanov, Y. Lysenko, M. E. Krasnyanskii, 1972 .

Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.

K. Jacobson, Zhang-Guo Gao, A. Ivanov, 2009, Journal of medicinal chemistry.

Application of the bridgehead fragments for the design of conformationally restricted melatonin analogues.

N. S. Zefirov, A. A. Ivanova, A. Ivanov, 2011, Bioorganic chemistry.

In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer

G. Mills, Ken Chen, C. Creighton, 2018, Nature Communications.

Effect of some factors on the stabilizing activity of oligoarylenes

A. Berlin, A. Ivanov, A. P. Firsov, 1973 .

The OncoPPi Portal: an integrative resource to explore and prioritize protein–protein interactions for cancer target discovery

Lee A. D. Cooper, Haian Fu, Andrei A. Ivanov, 2018, Bioinform..

The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

Lee A. D. Cooper, Qi Qi, Carlos S. Moreno, 2017, Nature Communications.

MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development

Lee A D Cooper, Margaret A. Johns, Yuhong Du, 2017, PloS one.

Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.

Rina Su, Haian Fu, Andrei A. Ivanov, 2016, Journal of molecular cell biology.

Molecular modeling of a PAMAM-CGS21680 dendrimer bound to an A2A adenosine receptor homodimer.

K. Jacobson, A. Ivanov, 2008, Bioorganic & medicinal chemistry letters.

OncoPPi-informed discovery of Mitogen-Activated Protein Kinase Kinase 3 as a novel binding partner of c-Myc

Margaret A. Johns, Fadlo R. Khuri, Yuhong Du, 2017, Oncogene.

Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.

A. Ivanov, N. Zefirov, V. Palyulin, 2007, Journal of molecular graphics & modelling.

Saccharomyces cerevisiae Apn1 mutation affecting stable protein expression mimics catalytic activity impairment: implications for assessing DNA repair capacity in humans.

N. Degtyareva, P. Doetsch, A. Ivanov, 2012, DNA repair.

Investigation of the anionic polymerization of phenylacetylene in the presence of lithium initiators

A. Berlin, A. Ivanov, A. I. Kadantseva, 1975 .

AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay

Qi Qi, Xiulei Mo, Margaret A. Johns, 2017, Molecular Pharmacology.

Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.

Dov Barak, Kenneth A Jacobson, K. Jacobson, 2009, Journal of medicinal chemistry.

Structure and Function of G Protein-Coupled Receptors Studied Using Sequence Analysis, Molecular Modeling and Receptor Engineeri

K. Jacobson, I. Tikhonova, S. Costanzi, 2007 .

Inhibition of cumene oxidation by polyarylenes

A. Berlin, A. Ivanov, 2007 .

Inhibiting activity and thermooxidative stability of the oxidative dehydro‐polycondensation products of diphenylamine

A. Berlin, A. Ivanov, I. I. Mirotvortsev, 2007 .

Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.

A. Ivanov, N. Zefirov, I. Baskin, 2005, Journal of Medicinal Chemistry.

1E7‐03, a low MW compound targeting host protein phosphatase‐1, inhibits HIV‐1 transcription

K. Kehn-Hall, S. Nekhai, A. Üren, 2014, British journal of pharmacology.

Application of the bridgehead fragments for the design of conformationally restricted melatonin analogues.

A. A. Ivanova, A. Ivanov, O. Zefirova, 2011, Bioorganic chemistry.